List view / Grid view
24 June 2015 | By Victoria White
The first patient has been enrolled in Pfizer’s RESET study of rivipansel for the treatment of vaso-occlusive crisis in patients with sickle cell disease...
24 June 2015 | By Victoria White
Otsuka and Lundbeck have announced newly released subgroup analysis of data from the QUALIFY study of Abilify Maintena (aripiprazole once-monthly)...
24 June 2015 | By
NICE has today published preliminary recommendations on ciclosporin (Ikervis) for treating severe keratitis in adults with dry eye disease...
23 June 2015 | By Victoria White
Data presented at ASCO 2015 suggests that the Opdivo/Yervoy combination of immunotherapies to treat metastatic melanoma will shape the therapeutic landscape...
23 June 2015 | By Victoria White
Alexion Pharmaceuticals has successfully completed its acquisition of Synageva BioPharma, strengthening Alexion's position in devastating and rare diseases...
The expanded service manages in-market supply to end users – hospitals, pharmacies, doctors, dentists, wholesalers, vaccination centres in 8 countries initially: Austria, Denmark, France, Italy, Spain, UK, Germany, Belgium, and Poland expected to follow later in the year.
23 June 2015 | By Victoria White
Latest figures published by Public Health England (PHE) show there were 439,243 sexually transmitted infections (STIs) reported in England in 2014...
23 June 2015 | By Victoria White
Roche has announced new data from the first study of the novel humanised bispecific antibody ACE910 (RG6013) in people with severe haemophilia A...
23 June 2015 | By Victoria White
Internis Pharmaceuticals has launched a new MHRA-licensed and approved vitamin D (colecalciferol) formulation in the UK - Fultium-D3 Drops...
23 June 2015 | By Victoria White
Tekmira has announced that the Phase II clinical trial of TKM-Ebola-Guinea has reached a predefined statistical endpoint and enrollment has been closed.
23 June 2015 | By Victoria White
NICE has updated and redesigned its guideline to support GPs and other primary care professionals to recognise the signs and symptoms of cancer...
22 June 2015 | By Celsis International
Celsis Advance II™ system helps Home, Beauty and Pharmaceutical product manufacturers enhance quality assurance while reducing manufacturing cycle times and inventory requirements...
22 June 2015 | By Victoria White
Results from an interim analysis of a Phase III study demonstrate that idarucizumab immediately reversed the anticoagulant effect of dabigatran...
22 June 2015 | By Victoria White
Full results from the second part of a Phase 3 trial evaluating the safety and efficacy of andexanet alfa as a reversal agent of Eliquis have been announced...
22 June 2015 | By Victoria White
Pfizer has entered into an agreement with GlaxoSmithKline to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for $130 million...
